![]() | Up a level |
Din, Shahida, Kent, Alexandra, Pollok, Richard C, Meade, Susanna, Kennedy, Nicholas A, Arnott, Ian, Beattie, R Mark, Chua, Felix, Cooney, Rachel, Dart, Robin J et al (show 24 more authors)
(2020)
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel.
GUT, 69 (10).
1769 - 1777.
Kennedy, Nicholas A, Jones, Gareth-Rhys, Lamb, Christopher A, Appleby, Richard, Arnott, Ian, Beattie, R Mark, Bloom, Stuart, Brooks, Alenka J, Cooney, Rachel, Dart, Robin J et al (show 26 more authors)
(2020)
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.
GUT, 69 (6).
984 - 990.
Nelson, Andrew ORCID: 0000-0001-6665-4929, Stewart, Christopher J
ORCID: 0000-0002-6033-338X, Kennedy, Nicholas A
ORCID: 0000-0003-4368-1961, Lodge, John K
ORCID: 0000-0001-6014-4952, Tremelling, Mark, Probert, Chris S
ORCID: 0000-0003-4550-0239, Parkes, Miles, Mansfield, John C, Smith, Darren L
ORCID: 0000-0003-4925-467X, Hold, Georgina L
ORCID: 0000-0001-7573-3397 et al (show 4 more authors)
(2020)
The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and Individuals Without Gastrointestinal Inflammation.
Journal of Crohn's & colitis.
Kennedy, Nicholas A, Lamb, Christopher A, Berry, Susan H, Walker, Alan W, Mansfield, John, Parkes, Miles, Simpkins, Rachel, Tremelling, Mark, Nutland, Sarah, Parkhill, Julian et al (show 4 more authors)
(2018)
The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease.
INFLAMMATORY BOWEL DISEASES, 24 (3).
583 - 592.
Mowat, Craig, Arnott, Ian, Cahill, Aiden, Smith, Malcolm, Ahmad, Tariq, Subramanian, Sreedhar ORCID: 0000-0002-6483-1730, Travis, Simon, Morris, John, Hamlin, John, Dhar, Anjan et al (show 34 more authors)
(2016)
Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.
LANCET GASTROENTEROLOGY & HEPATOLOGY, 1 (4).
273 - 282.